These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2532460)

  • 1. Clinical pharmacology of cilazapril.
    Kleinbloesem CH; Van Brummelen P; Francis RJ; Wiegand UW
    Am J Med; 1989 Dec; 87(6B):45S-49S. PubMed ID: 2532460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical pharmacology of cilazapril.
    Kleinbloesem CH; van Brummelen P; Francis RJ; Wiegand UW
    Drugs; 1991; 41 Suppl 1():3-10. PubMed ID: 1712269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A review of the preclinical cardiovascular pharmacology of cilazapril, a new angiotensin converting enzyme inhibitor.
    Waterfall JF
    Br J Clin Pharmacol; 1989; 27 Suppl 2(Suppl 2):139S-150S. PubMed ID: 2527528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A pharmacokinetic study of cilazapril in elderly and young volunteers.
    Williams PE; Brown AN; Rajaguru S; Walters GE; McEwen J; Durnin C
    Br J Clin Pharmacol; 1989; 27 Suppl 2(Suppl 2):211S-215S. PubMed ID: 2527535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of food on the pharmacokinetics and ACE inhibition of cilazapril.
    Massarella JW; DeFeo TM; Brown AN; Lin A; Wills RJ
    Br J Clin Pharmacol; 1989; 27 Suppl 2(Suppl 2):205S-209S. PubMed ID: 2527534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cilazapril. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in cardiovascular disease.
    Deget F; Brogden RN
    Drugs; 1991 May; 41(5):799-820. PubMed ID: 1712710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pharmacokinetics and angiotensin converting enzyme inhibition dynamics of cilazapril in essential hypertension.
    Meredith PA; Elliott HL; Reid JL; Francis RJ
    Br J Clin Pharmacol; 1989; 27 Suppl 2(Suppl 2):263S-266S. PubMed ID: 2548553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pharmacokinetics and bioavailability of cilazapril in normal man.
    Williams PE; Brown AN; Rajaguru S; Francis RJ; Walters GE; McEwen J; Durnin C
    Br J Clin Pharmacol; 1989; 27 Suppl 2(Suppl 2):181S-188S. PubMed ID: 2527531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pharmacokinetics and dose proportionality of cilazapril.
    Massarella J; DeFeo T; Lin A; Limjuco R; Brown A
    Br J Clin Pharmacol; 1989; 27 Suppl 2(Suppl 2):199S-204S. PubMed ID: 2527533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of ACE inhibition with cilazapril on splanchnic and systemic haemodynamics in man.
    Gasic S; Heinz G; Kleinbloesem C; Korn A
    Br J Clin Pharmacol; 1989; 27 Suppl 2(Suppl 2):225S-234S. PubMed ID: 2548552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and effects on renal function following cilazapril and hydrochlorothiazide alone and in combination in healthy subjects and hypertensive patients.
    Nilsen OG; Sellevold OF; Romfo OS; Smedsrud A; Grynne B; Williams PE; Kleinbloesem CH
    Br J Clin Pharmacol; 1989; 27 Suppl 2(Suppl 2):323S-328S. PubMed ID: 2527546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cilazapril. A review.
    Szucs T
    Drugs; 1991; 41 Suppl 1():18-24. PubMed ID: 1712267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of cilazapril in patients with renal failure.
    Fillastre JP; Moulin B; Godin M; Williams PE; Brown AN; Francis RJ; Pinta P; Manfredi R
    Br J Clin Pharmacol; 1989; 27 Suppl 2(Suppl 2):275S-282S. PubMed ID: 2527539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cilazapril and enalapril inhibit local angiotensin I conversion in human veins but lack direct venodilating properties.
    Eichler HG; Blöchl-Daum B; Kyrle PA; Gasic S
    J Cardiovasc Pharmacol; 1989 Aug; 14(2):248-52. PubMed ID: 2476598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of intravenous cilazaprilat in normal volunteers.
    Whitehead EM; Walters GE; Williams PE; Johnston GD
    Br J Clin Pharmacol; 1989 Jun; 27(6):873-5. PubMed ID: 2757899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between plasma concentration of cilazapril and haemodynamic and hormonal effects in healthy man.
    Burnier M; Mooser V; Nussberger J; Waeber B; Brunner HR
    Br J Clin Pharmacol; 1989; 27 Suppl 2(Suppl 2):189S-197S. PubMed ID: 2527532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin-converting enzyme (ACE)-inhibition in cirrhosis. Pharmacokinetics and dynamics of the ACE-inhibitor cilazapril (Ro 31-2848).
    Gross V; Treher E; Haag K; Neis W; Wiegand U; Schölmerich J
    J Hepatol; 1993 Jan; 17(1):40-7. PubMed ID: 8445218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of acute ACE inhibition on atrial natriuretic peptide.
    Doorenbos CJ; van Brummelen P
    Br J Clin Pharmacol; 1989; 27 Suppl 2(Suppl 2):243S-247S. PubMed ID: 2527537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Steady-state pharmacokinetics and pharmacodynamics of cilazapril in the presence and absence of cyclopenthiazide.
    Krum H; Jackson B; Conway EL; Howes LG; Johnston CI; Louis WJ
    J Cardiovasc Pharmacol; 1992 Sep; 20(3):451-7. PubMed ID: 1279292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A pharmacokinetic study of cilazapril in patients with congestive heart failure.
    Rosenthal E; Francis RJ; Brown AN; Rajaguru S; Williams PE; Steiner J; Curry PV
    Br J Clin Pharmacol; 1989; 27 Suppl 2(Suppl 2):267S-273S. PubMed ID: 2548554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.